BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 27 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,866,518 | +27.6% | 55,306,226 | +30.1% | 2.72% | -22.1% |
Q2 2023 | $42,983,572 | +27.5% | 42,526,167 | +31.1% | 3.50% | +40.6% |
Q1 2023 | $33,719,632 | +60468.4% | 32,443,000 | +62175.4% | 2.49% | -34.0% |
Q4 2022 | $55,672 | -99.9% | 52,096 | +0.2% | 3.77% | +2.0% |
Q3 2022 | $52,121,000 | +2.6% | 52,002 | +2.8% | 3.69% | +8.9% |
Q2 2022 | $50,777,000 | +67.7% | 50,586 | +68.3% | 3.39% | +64.8% |
Q1 2022 | $30,276,000 | -36.7% | 30,062 | -34.5% | 2.06% | -46.4% |
Q4 2021 | $47,842,000 | +45.0% | 45,919 | +40.0% | 3.84% | +37.0% |
Q3 2021 | $32,986,000 | – | 32,795 | – | 2.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |